Diagnostic use of calprotectin to prevent contrast media induced acute kidney injury

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00005416

Enrollment

894

Registered

2013-11-08

Start date

2014-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N17 N99.0

Interventions

Group 1: Phase I of the study: Assessment of urinary concentration of calprotectin to identify patients at increased risk for contrast induced acute kidney injury. Group 2: Phase II of the study: Admi

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Anticipated cardiac catheter examination

Exclusion criteria

Exclusion criteria: Anuria, age < 18 years, participation in another study, patients unable to give informed consent, eGFR < 60 ml/min per 1.73m2, pyuria, urothelial carcinoma, metastatic cancer , coronary angiography in acute myocardial infarction, congestive heart failure NYHA III-IV

Design outcomes

Primary

Measure	Time frame
Incidence of contrast induced acute kidney injury - assessment of renal function by serum creatinine	—

Secondary

Measure	Time frame
Proteinuria, dip-stick urinary examination	—

Countries

Germany

Contacts

Public ContactNikolaos Pagonas

Medizinische Klinik I, Universitätsklinik Marienhospital Herne

nikolaos.pagonas@marienhospital-herne.de02323-4995148

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026